Cargo-loading of hybrid cowpea chlorotic mottle virus capsids via a co-expression approach

Capsids of the cowpea chlorotic mottle virus (CCMV) are great candidates for the development into in vivo catalytic or therapeutic nanocarriers. However, due to their limited intrinsic stability at physiological pH, thus far no methods exist for incorporating cargo into these nanoparticles in cellul...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 577; pp. 99 - 104
Main Authors Timmermans, Suzanne B.P.E., Mesman, Rob, Blezer, Kim J.R., van Niftrik, Laura, van Hest, Jan C.M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Capsids of the cowpea chlorotic mottle virus (CCMV) are great candidates for the development into in vivo catalytic or therapeutic nanocarriers. However, due to their limited intrinsic stability at physiological pH, thus far no methods exist for incorporating cargo into these nanoparticles in cellulo. Here, we employ a stabilized VW1-VW8 ELP-CCMV variant for the development of a co-expression-based cargo-loading approach. Co-expression of the non-functionalized VW1-VW8 ELP-CCMV coat protein with fusion proteins with enhanced green fluorescent protein (mEGFP) and pyrrolysine synthase D (PylD) in E. coli enabled the purification of cargo-loaded capsids from the bacteria directly either via affinity chromatography or PEG-precipitation and subsequent size exclusion chromatography. Microscopy results indicated that the co-expression does not harm the E. coli cells and that proper folding of the mEGFP domain is not hampered by the co-assembly. Our co-expression strategy is thus a suitable approach to produce cargo-loaded CCMV nanoparticles. •We developed an in cellulo cargo loading approach for CCMV nanoparticles.•Capsid and cargo were co-expressed, co-assembled and copurified.•This strategy was also successful for the incorporation of functional proteins into CCMV.•Our approach could in the future be extended to produce in cellulo artificial organelles.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2022.10.011